Pharma & HealthcareTop Companies
Pharma & Healthcare

Top 5-Hydroxytryptophan (5-HTP) Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

Industry

Pharma & Healthcare

Published

Jan 2026

Share:

Pharma & Healthcare

Top 5-Hydroxytryptophan (5-HTP) Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

$3,590

Choose License Type

Only one user can use this report

Additional users can access this report

You can share within your company

Company Contents

Quick Facts & Snapshot

2025 Market Size (US$)
44.20 Million
2026 Forecast (US$)
47.70 Million
2032 Forecast (US$)
74.90 Million
CAGR (2025-2032)
7.90%

Summary

The 5-Hydroxytryptophan (5-HTP) market is transitioning from niche supplement segment to structured growth phase, supported by rising mood, sleep, and cognitive health demand. With global value reaching US$ 44.20 Million in 2025 and a 7.90% CAGR projected to 2032, leading 5-Hydroxytryptophan (5-HTP) market companies consolidate share through quality, regulatory compliance, and differentiated formulations.

2025 Revenue of Top 5-Hydroxytryptophan (5-HTP) Suppliers
ReportMines Logo

Source: Secondary Information and ReportMines Research Team - 2026

Ranking Methodology

Rankings of 5-Hydroxytryptophan (5-HTP) market companies are based on a composite score integrating quantitative and qualitative metrics. Core inputs include estimated 2025 5-HTP revenue, three-year revenue growth, and share in key regions and channels (nutraceutical brands, contract manufacturing, pharma-grade supply). Additional weight is assigned to technology differentiation, IP around extraction and purification, portfolio breadth across dosage forms, and depth of clinical or regulatory dossiers. Operational criteria cover global manufacturing footprint, quality certifications, supply reliability, and ability to provide long-term supply and formulation support to brand owners. Strategic factors evaluate M&A, partnerships, and R&D intensity in mood, sleep, and metabolic health applications. Each company receives scores on all dimensions, normalized to a 100-point scale; final ranking reflects the aggregated score, with transparent emphasis on market impact and future growth potential.

Top 10 Companies in 5-Hydroxytryptophan (5-HTP)

1
VitaNutraceuticals International
1,200
Branded nutraceutical ingredients and finished-dose supplements focused on mood and sleep health.
New Jersey, USA
Standardized Griffonia simplicifolia-sourced 5-HTP with enhanced purity and low-impurity profiles.
North America, Europe, Online global.
Launched sustained-release 5-HTP capsules, expanded distribution partnerships in North America and Western Europe.
Direct to major supplement brands, private-label manufacturing, e-commerce own brand.
≈ 15.40%
cGMP, NSF, ISO 22000, Non-GMO Project Verified lines.
US$ 6.80 Million
2
SereniLife Bioactive Ingredients
780
Specialty botanical extracts and clinically positioned nutraceutical actives.
Basel, Switzerland
High-assay pharma-adjacent 5-HTP for premium mood and sleep formulations.
Europe, North America, Asia Pacific.
Signed multi-year supply deals with European pharma-nutrition hybrids; invested in clean-label extraction lines.
B2B ingredient sales to supplement, OTC, and functional food companies.
≈ 13.30%
GMP, ISO 9001, FSSC 22000, multiple EU pharmacopeia alignments.
US$ 5.90 Million
3
Pacifica Herbal Labs
620
Plant-based nutraceuticals and vegan-certified dietary supplements.
Vancouver, Canada
Organic-certified Griffonia sourcing and clean-label 5-HTP gummies and powders.
North America, Japan, Australia.
Launched child-safe low-dose 5-HTP line; entered strategic JV in Japan for functional snacks.
Retail brands, natural health chains, D2C subscription platforms.
≈ 10.60%
cGMP, USDA Organic, Canada NNHPD-compliant, Vegan Society.
US$ 4.70 Million
4
Zenova Therapeutics Nutrition Division
950
Nutritional APIs and functional ingredients for pharma and FOSHU markets.
Tokyo, Japan
5-HTP APIs for combination mood-support formulas and ready-to-drink beverages.
Japan, South Korea, Southeast Asia.
Filed FOSHU applications for 5-HTP drinks; partnered with regional convenience-store chains.
B2B to beverage, pharma, and large supplement manufacturers.
≈ 9.30%
PIC/S GMP, ISO 14001, HACCP.
US$ 4.10 Million
5
GreenOrigins Phytoceuticals
540
Sustainably sourced phytoceutical ingredients for European brands.
Hamburg, Germany
Traceable, fair-trade Griffonia supply and low-solvent 5-HTP extraction.
DACH, Nordics, Benelux.
Secured long-term sourcing contracts in West Africa, launched carbon-neutral ingredient program.
Ingredients to EU nutraceuticals, white-label capsule production.
≈ 8.10%
EU Organic, Fair for Life, ISO 22000.
US$ 3.60 Million
6
NutraBridge Consumer Health
430
Mass-market dietary supplements and private-label contract manufacturing.
Texas, USA
High-volume 5-HTP capsules and tablets for retail chains.
USA, Canada, Mexico.
Expanded production capacity by 30.00%, added sugar-free 5-HTP gummy line.
Big-box retailers, pharmacy chains, online marketplaces.
≈ 7.00%
cGMP, NSF, retailer-audited quality programs.
US$ 3.10 Million
7
HerbNova Lifescience
510
Botanical APIs and standardized herbal extracts for export markets.
Bengaluru, India
Cost-competitive 5-HTP ingredient supply at scale with flexible specifications.
India, Middle East, Europe (via distributors).
Upgraded extraction facility to EU-compliant standards; growing presence in Middle East and Africa.
Export to ingredient traders and contract manufacturers.
≈ 6.10%
WHO-GMP, ISO 9001, HALAL, KOSHER.
US$ 2.70 Million
8
Andes Nutraceutical Exports
290
Export-focused botanical ingredients for Americas and Europe.
Santiago, Chile
5-HTP powders integrated with other Andean botanicals for mood blends.
Latin America, USA, Spain, Portugal.
Opened Miami sales office; launched bilingual B2B e-commerce portal.
Ingredient distributors, regional supplement brands.
≈ 5.00%
GMP, ISO 22000, local INVIMA-equivalent registrations.
US$ 2.20 Million
9
NeuroBalance Formulations
210
Brain-health-focused finished products under owned brands.
Manchester, United Kingdom
5-HTP combined with magnesium, B6, and adaptogens in advanced delivery formats.
UK, Ireland, selective EU online.
Entered pharmacy chains across UK and Ireland; piloting telehealth-linked supplement subscriptions.
D2C, pharmacies, specialty brain-health clinics.
≈ 4.30%
UK GMP, MHRA-compliant processes for borderline products.
US$ 1.90 Million
10
CalmSphere Online Nutrition
160
Digital-first wellness brand focused on stress and sleep solutions.
Sydney, Australia
Direct-to-consumer 5-HTP sachets and personalized stack kits.
Australia, New Zealand, Southeast Asia cross-border.
Launched app-based personalization engine; expanded fulfilment hubs in Singapore and New Zealand.
Online subscription, influencers, cross-border e-commerce.
≈ 3.60%
TGA-listed products where applicable, cGMP contract manufacturing partners.
US$ 1.60 Million

Source: Secondary Information and ReportMines Research Team - 2026

Detailed Company Profiles

1

VitaNutraceuticals International

VitaNutraceuticals International is a leading North American supplier of branded 5-HTP ingredients and finished nutraceutical products for mood and sleep support.

Key Financials: 2025 5-Hydroxytryptophan (5-HTP) revenue US$ 6.80 Million; 5-HTP segment CAGR 2025-2030 estimated at 8.40%.
Flagship Products: NeuroSerene 5-HTP, SleepBalance SR 5-HTP, MoodFlex Pure 5-HTP.
2025-2026 Actions: Expanded SR-tablet capacity, strengthened Griffonia sourcing contracts, and launched co-branded programs with major retail supplement banners.
Three-line SWOT: Strong brand recognition and regulatory track record; Heavy reliance on North American demand; Opportunity—premium SR and clean-label 5-HTP globally.
Notable Customers: CVS Health private label, Walmart house brands, leading U.S. nutraceutical marketers.
2

SereniLife Bioactive Ingredients

SereniLife Bioactive Ingredients specializes in high-purity botanical actives, supplying pharma-adjacent 5-HTP to European and global premium health brands.

Key Financials: 2025 5-Hydroxytryptophan (5-HTP) revenue US$ 5.90 Million; R&D spend equal to 9.80% of total company revenue.
Flagship Products: SereniLift 5-HTP 98, SereniLift Ultra-Control, NeuroCalm Clinical 5-HTP.
2025-2026 Actions: Completed clinical substantiation program for mood-support claims and invested in solvent-free extraction with reduced carbon footprint.
Three-line SWOT: Strong clinical and regulatory capabilities; Premium pricing limits penetration in value segments; Opportunity—pharma-nutrition collaborations in Europe and Asia.
Notable Customers: Major EU OTC houses, top Swiss and German nutraceutical brands, select Japanese FOSHU players.
3

Pacifica Herbal Labs

Pacifica Herbal Labs is a plant-based specialist delivering organic, vegan-certified 5-HTP supplements across gummies, capsules, and functional powders.

Key Financials: 2025 5-Hydroxytryptophan (5-HTP) revenue US$ 4.70 Million; online channel accounts for 61.00% of 5-HTP sales.
Flagship Products: PacificCalm 5-HTP Gummies, OceanNight 5-HTP Powder, VeganSerotonin Capsules.
2025-2026 Actions: Introduced pediatric-compliant formulations, expanded Amazon and direct-to-consumer presence, and formed JV for Japan-specific flavor systems.
Three-line SWOT: Strong positioning in vegan and organic niches; Limited B2B ingredient exposure; Opportunity—expansion into functional beverages and kids’ health.
Notable Customers: Whole Foods-affiliated chains, Amazon shoppers, specialty natural-health retailers in North America and Japan.
4

Zenova Therapeutics Nutrition Division

Zenova Therapeutics Nutrition Division integrates 5-HTP into pharma-grade APIs and FOSHU-oriented functional beverages for Asian markets.

Key Financials: 2025 5-Hydroxytryptophan (5-HTP) revenue US$ 4.10 Million; operating margin on nutrition division around 17.60%.
Flagship Products: Zenova-5HTP API, ZenCalm RTD Drink, SereneShot 5-HTP Beverage Premix.
2025-2026 Actions: Expanded RTD filling capacity, strengthened regulatory dossiers for FOSHU claims, and secured convenience-store distribution in Japan.
Three-line SWOT: Strong pharma manufacturing standards; Highly concentrated exposure to Japan; Opportunity—export of RTD concepts across broader Asia Pacific.
Notable Customers: Japanese beverage conglomerates, regional pharma-nutrition companies, contract beverage fillers.
5

GreenOrigins Phytoceuticals

GreenOrigins Phytoceuticals focuses on sustainability-led phytoceutical ingredients, emphasizing traceable and ethical 5-HTP supply for European brands.

Key Financials: 2025 5-Hydroxytryptophan (5-HTP) revenue US$ 3.60 Million; over 70.00% of 5-HTP volume certified organic or fair-trade.
Flagship Products: GreenOrigins 5-HTP FairTrade, EcoSerotonin 5-HTP, PureTrace Griffonia Extract.
2025-2026 Actions: Rolled out carbon-neutral product portfolio, deepened co-operative partnerships with West African Griffonia farmers, and expanded DACH sales team.
Three-line SWOT: Compelling sustainability narrative; Higher sourcing costs than some Asian competitors; Opportunity—EU retailers’ sustainability commitments and eco-label demand.
Notable Customers: German pharmacy brands, Nordic eco-supplement labels, specialty organic chains across Europe.
6

NutraBridge Consumer Health

NutraBridge Consumer Health manufactures large-volume 5-HTP supplements and private-label SKUs for mass-market retailers across North America.

Key Financials: 2025 5-Hydroxytryptophan (5-HTP) revenue US$ 3.10 Million; private-label contracts account for 82.00% of 5-HTP revenue.
Flagship Products: BridgeCalm 5-HTP, SleepBridge Dual-Action 5-HTP, store-brand 5-HTP tablets.
2025-2026 Actions: Added sugar-free gummies line, increased tablet compression capacity, and pursued multi-year agreements with big-box retailers.
Three-line SWOT: Strong cost efficiency and scale; Limited brand equity under own labels; Opportunity—value-positioned 5-HTP as economic uncertainty boosts budget brands.
Notable Customers: Costco and Walmart private labels, regional supermarket chains, online marketplace resellers.
7

HerbNova Lifescience

HerbNova Lifescience is an India-based botanical API exporter providing competitively priced 5-HTP ingredients to global traders and manufacturers.

Key Financials: 2025 5-Hydroxytryptophan (5-HTP) revenue US$ 2.70 Million; export sales form 88.00% of total revenue.
Flagship Products: HerbNova 5-HTP 95, Griffonia Extract 20, custom-spec 5-HTP concentrates.
2025-2026 Actions: Upgraded facilities to meet EU customer audits, improved solvent-recovery systems, and expanded distributor network in Middle East and Eastern Europe.
Three-line SWOT: Cost-competitive manufacturing; Still building reputation in regulated markets; Opportunity—outsource strategies of Western 5-HTP brands seeking margin.
Notable Customers: European ingredient traders, Middle Eastern supplement manufacturers, Indian contract formulators.
8

Andes Nutraceutical Exports

Andes Nutraceutical Exports supplies 5-HTP and complementary botanicals from Latin America to regional and transatlantic nutraceutical customers.

Key Financials: 2025 5-Hydroxytryptophan (5-HTP) revenue US$ 2.20 Million; revenue mix roughly 60.00% exports, 40.00% regional LATAM sales.
Flagship Products: AndesCalm 5-HTP Blend, MoodAndes Complex, SereneAndes Bulk Powder.
2025-2026 Actions: Opened U.S. sales office, strengthened logistics from Chile to North America, and launched bilingual digital B2B storefront.
Three-line SWOT: Strategic Americas location and bilingual capabilities; Smaller scale versus global leaders; Opportunity—fast-growing Latin American sleep and mood segment.
Notable Customers: Brazilian supplement brands, Mexican contract manufacturers, U.S. Hispanic-focused nutraceutical labels.
9

NeuroBalance Formulations

NeuroBalance Formulations is a specialist brain-health brand integrating 5-HTP into premium, clinically inspired formulations sold mainly direct-to-consumer.

Key Financials: 2025 5-Hydroxytryptophan (5-HTP) revenue US$ 1.90 Million; online subscription revenues represent 55.00% of total sales.
Flagship Products: NeuroBalance Night, Focus&Calm 5-HTP Stack, NeuroBalance Microdose 5-HTP.
2025-2026 Actions: Rolled out telehealth partnerships, expanded into Ireland and selected EU markets, and introduced trial-size packs for online acquisition.
Three-line SWOT: Strong specialization and curated brain-health portfolio; Limited geographic footprint; Opportunity—digital health integrations and bundle offerings.
Notable Customers: UK online consumers, private neuro-wellness clinics, specialty e-pharmacies.
10

CalmSphere Online Nutrition

CalmSphere Online Nutrition is a digital-native wellness brand delivering personalized 5-HTP and stress-support stacks via subscription in Asia-Pacific.

Key Financials: 2025 5-Hydroxytryptophan (5-HTP) revenue US$ 1.60 Million; customer churn maintained below 11.50% annually.
Flagship Products: CalmSphere Night Pack, On-the-Go 5-HTP Sticks, CalmSphere Personalized Stack Kits.
2025-2026 Actions: Deployed recommendation engine using lifestyle data, expanded cross-border shipping nodes, and increased influencer-led campaigns in Southeast Asia.
Three-line SWOT: Agile digital marketing and personalization; Dependent on third-party manufacturers; Opportunity—scaling subscriptions across Asia-Pacific’s young demographics.
Notable Customers: Australian online consumers, Singapore and Malaysian cross-border buyers, wellness-app partners.

SWOT Leaders

VitaNutraceuticals International

SWOT Snapshot

SWOT
Strengths

Strong North American distribution, broad 5-HTP portfolio, and robust regulatory and quality-compliance infrastructure.

Weaknesses

Overexposure to North American retail cycles and limited on-the-ground sales presence in Asia-Pacific.

Opportunities

International expansion into Europe and Asia, plus further premiumization via sustained-release and combination formulas.

Threats

Price pressure from lower-cost suppliers and tightening supplement regulations around mood claims.

SereniLife Bioactive Ingredients

SWOT Snapshot

SWOT
Strengths

Clinical data package, pharma-level documentation, and strong positioning with European premium health and OTC companies.

Weaknesses

Higher price points and smaller presence in mass-market or e-commerce-led channels compared with competitors.

Opportunities

Collaborations with pharma and medical-nutrition players and entry into emerging Asia markets seeking documented ingredients.

Threats

Generic competitors eroding premium pricing and regulatory shifts affecting health-claim wording in Europe.

Pacifica Herbal Labs

SWOT Snapshot

SWOT
Strengths

Strong resonance with vegan and organic consumers and diversified portfolio across gummies, powders, and capsules.

Weaknesses

Limited B2B ingredient footprint and dependence on online platforms for customer acquisition.

Opportunities

Expansion into functional beverages, children’s formulations, and broader Asia-Pacific distribution partnerships.

Threats

Intensifying competition in plant-based supplements and potential constraints in organic Griffonia sourcing.

5-Hydroxytryptophan (5-HTP) Market Regional Competitive Landscape

North America remains the largest regional contributor to global 5-HTP demand, driven by strong OTC supplement penetration, sleep-health awareness, and robust e-commerce activity. VitaNutraceuticals International and NutraBridge Consumer Health anchor the competitive field, while Pacifica Herbal Labs leverages organic and vegan propositions to win share among younger, digitally engaged demographics.

Europe is characterized by stringent regulatory scrutiny, sophisticated pharmacy channels, and high preference for documented, high-purity ingredients. SereniLife Bioactive Ingredients and GreenOrigins Phytoceuticals lead by combining regulatory strength and sustainability narratives, while NeuroBalance Formulations carves a niche through clinically inspired brain-health stacks targeted at UK and Northern European consumers.

Asia Pacific shows the fastest relative growth, supported by rising stress, long working hours, and expanding middle-class spending on mental well-being. Zenova Therapeutics Nutrition Division anchors the Japanese and regional FOSHU-adjacent space, whereas CalmSphere Online Nutrition and Pacifica Herbal Labs tap cross-border e-commerce flows from Australia and North America into Southeast Asia.

Latin America remains an underpenetrated but rapidly formalizing market, where sleep and mood-support products increasingly enter mainstream retail and pharmacy chains. Andes Nutraceutical Exports operates as a critical supplier of 5-HTP blends into Brazil, Mexico, and the broader region, benefiting from regional familiarity and Spanish-Portuguese language capabilities for technical and marketing support.

Middle East and Africa are emerging as secondary growth frontiers, with demand still concentrated among higher-income urban consumers and expatriate populations. HerbNova Lifescience leverages cost-competitive 5-HTP ingredient exports, often via regional traders, while European and U.S. 5-Hydroxytryptophan (5-HTP) market companies cautiously test the region through online channels and limited retail placements.

Digital cross-border commerce increasingly blurs regional boundaries, enabling Asia-Pacific and Latin American consumers to access North American and European 5-HTP brands directly. Pacifica Herbal Labs, CalmSphere Online Nutrition, and NeuroBalance Formulations are particularly active in optimized logistics, subscription models, and localized digital marketing, intensifying competition across traditionally distinct regional markets.

Challengers & Emerging Players

Emerging Challengers & Disruptive Start-Ups

SerotoGenix Labs
Disruptor
USA

Developing micro-encapsulated 5-HTP beads enabling targeted intestinal release and reduced nausea, aimed at sensitive consumers and clinical-adjacent formulations.

GriffoniaCo West Africa
Disruptor
Ghana

Vertically integrated Griffonia grower and processor promoting fair-trade, blockchain-traceable 5-HTP ingredients for sustainability-focused supplement brands worldwide.

CalmByte Digital Health
Disruptor
Germany

Combines app-based stress tracking with AI-generated 5-HTP stacking recommendations, partnering with manufacturers for personalized, subscription-based fulfillment.

NutriWave Japan KK
Disruptor
Japan

Creates 5-HTP-infused functional beverages and jelly sticks tailored to convenience-store formats and on-the-go consumption in dense urban markets.

BioHarmony Innovations
Disruptor
India

Focuses on synergistic 5-HTP blends with adaptogens and nootropics, targeting value-conscious emerging-market consumers via online marketplaces.

AndeanMind Wellness
Disruptor
Peru

Combines 5-HTP with indigenous botanicals in ethically marketed mood formulas, emphasizing indigenous partnerships and storytelling-driven differentiation.

5-Hydroxytryptophan (5-HTP) Market Future Outlook & Key Success Factors (2026-2032)

From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning 5-Hydroxytryptophan (5-HTP) market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.

Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards 5-Hydroxytryptophan (5-HTP)market companies that marry digital intelligence with manufacturing agility and regulatory foresight.

Frequently Asked Questions

Find answers to common questions about this company report.